Abstract

Determination of the capsule type of clinical isolates of Streptococcus pneumoniae is a prerequisite for epidemiological studies and further vaccine development. The Quellung reaction for serotyping is expensive and mostly done in reference centres. We wanted to evaluate whether Fourier-transformed infrared (FT-IR) spectroscopy is suitable for capsular type analysis and prediction of pneumococcal serotypes. We used the IR-Biotyper™ (Bruker) to create a database containing the spectra of 120 strains from invasive disease. The strains covered the 24 vaccine serotypes contained in the 13-valent conjugate vaccine (PCV13) and the 23-valent polysaccharide vaccine (PSV23). Hierarchical clustering analysis was performed. Finally, two different classification sets were created (PCV13 and PSV23). They were used to predict the serotype of 168 different challenge strains (invasive and non-invasive disease) covering 48 different serotypes (vaccine and non-vaccine types). FT-IR spectra from pneumococci (1300–800 cm−1) clustered along their serotype as determined by the Quellung reaction (120 strains, 24 different serotypes). Strains with unknown serotype fell within the cluster of the correct serotype, as long as the latter was represented in the database (168 strains, 48 different serotypes). Concordance between the Quellung reaction and FT-IR spectroscopy was excellent (kappa ≥ 0.75). FT-IR spectroscopy is a fast and cost-effective method to predict the capsular serotype of pneumococci.

Highlights

  • The capsule of Streptococcus pneumoniae is a significant pathogenicity factor, which protects pneumococci from phagocytosis and has an important role during colonization and invasive disease [1,2,3]

  • A total of 120 pneumococcal strains covering 24 different serotypes were used to create a database containing the infrared spectra of all PCV13 and PSV23 serotypes

  • Classification set 1 (“PCV13”) contained all 13 serotypes included in the PCV13 vaccine

Read more

Summary

Introduction

The capsule of Streptococcus pneumoniae is a significant pathogenicity factor, which protects pneumococci from phagocytosis and has an important role during colonization and invasive disease [1,2,3]. More than 90 different serotypes are currently described [10] and the commercially available pneumococcal vaccines contain up to 23 different capsule polysaccharides. SSI Diagnostica (formerly part of the Statens Serum Institute, Denmark) provides the necessary pool, type, group and factor sera according to the Danish system of pneumococcal serotyping [11]. This technique is expensive and time consuming. It is only available at specialized reference centres

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.